Search News
| 21.45 Delayed Data As of Jun 21 |  -0.85 / -3.81%Today’s Change | 11.85 Today|||52-Week Range 24.90 | +53.76% Year-to-Date |
| Previous close | 22.30 |
| Today’s open | 22.20 |
| Day’s range | 21.40 - 22.25 |
| Volume | 355,080 |
| Average volume (3 months) | 724,050 |
| Market cap | $1.6B |
| Earnings growth (last year) | -287.10% |
| Earnings growth (this year) | -23.77% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +26.70% |
| P/E ratio | NM |
| Price/Sales | 7.35 |
| Price/Book | 4.30 |
| Today’s change | Today’s % change | |
|---|---|---|
| XLRNAcceleron Pharma Inc | -0.42 | -1.12% |
| SGMOSangamo Therapeutics... | -1.93 | -10.66% |
| ---- | ||
| EPZMEpizyme Inc | -0.90 | -5.66% |
| Next reporting date | August 2, 2018 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $138.9M |
| Annual profit (last year) | -$88.1M |
| Net profit margin | -63.43% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler |
Chief Operating Officer & Chief Scientific Officer Ganesh Venkataraman Kaundinya |
Corporate headquarters Cambridge, Massachusetts |
